Clinical Trials in Los Angeles

Showing 12121-12140 of 14,465 trials

Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients

NCT01389700

Primary Objective: \- To determine the pharmacokinetics (PK) of a single intravenous (IV) dose of SAR279356 administered to intensive care unit (ICU) patients on mechanical ventilation Secondary Objectives: * To determine the safety and tolerability of SAR279356 * To evaluate the pharmacodynamics (PD) and immunogenicity of SAR279356 * Exploratory efficacy of SAR279356 on prevention of bacterial infections

Infection Prophylaxis

Sanofi7 participantsStarted Oct 2011

Los Angeles, California, United States • Stanford, California, United States • Jacksonville, Florida, United States +3 more locations

COMPLETEDPhase 2< 1 mile

A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease

NCT01578772

This research study is to see whether blood vessel function, an early sign of heart disease, improves in HIV-infected men and women who take telmisartan for 12 weeks. The investigators will be looking at how a blood vessel in the arm, called the brachial artery, changes in response to stress before and after taking telmisartan. To determine how well the blood vessel functions, the investigators will be using an ultrasound machine. Telmisartan is not an HIV medication. It is an FDA-approved medication designed to treat blood pressure, but has been shown to improve blood vessel function in HIV-negative people with and without high blood pressure. Telmisartan is made by Boehringer Ingelheim, and this trial is sponsored by The Campbell Foundation.

Endothelial Dysfunction

University of California, Los Angeles17 participantsStarted Aug 2012

Los Angeles, California, United States

Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients

A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease

Find Trials by Condition in Los Angeles

Study of a Stationary Cycling Intervention for Children With Spastic Diplegic Cerebral Palsy

Diabetes-Depression Care-management Adoption Trial

OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies

Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON]

Dose-Escalate Study to Investigate the Safety and Tolerability of T89 in Japanese

An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS

Open-label Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder

Comparison of Delivery Routes of Flu Vaccine in Adults

Expanded Dryvax Dilution Study in Previously Vaccinated Adults

Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

Cardiac Safety Study of Brentuximab Vedotin (SGN-35)

A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects

In-vivo Analysis and Clinical Evaluation of the Performance of a Fractional CO2 Laser System (eMatrixCO2)

Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes

California Transport Cooling Trial

CARTO® 3 System and Real Time Intracardiac Ultrasound

A Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)

Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control